This Greed Is Freaking Scary

By John Del Vecchio.  |  January 17, 2020

One of my favorite strategies is the “30-Second Millionaire” approach. I could care less about the news of the day. Read More

So, Mr. Bond…

By Charles Sizemore.  |  January 15, 2020

I admit that I got more excited than I should have when I found out that Daniel Craig would be coming back as James Bond in April’s No Time to Die. Read More

A Time of Historically High Returns

By John Del Vecchio.  |  January 9, 2020

It’s hard to believe that this year is the presidential election. I remember sitting up until 4 A.M. on November 9, 2016, watching the last presidential election unfold. Read More

A Super-Charged “Bull” ETF

By Adam O'Dell.  |  January 8, 2020

Last week I shared the first recommendation from my 20 Trade Ideas for 2020 and Beyond series. Read More

A Two-Pronged Approach to the Markets

By John Del Vecchio.  |  January 6, 2020

The new decade ushered in a massive volatility spike. Killing Major General Qassem Soleimani was enough to finally wake up the markets from its low volatility — now on the rise nearly daily. Read More

A More “Just” Market Fund

By Adam O'Dell.  |  January 3, 2020

Paul Tudor Jones is one of the most successful and wealthiest hedge fund managers of all time. Read More

Will Gold Shine in 2020?

By Charles Sizemore.  |  January 2, 2020

Since my beat is income, I don’t touch on gold very often. But we’re starting a new decade, so I’m giving gold a closer look. Read More

Emerging Markets Are the Place to Be in the 2020s

By John Del Vecchio.  |  December 31, 2019

Happy New Year’s Eve! We’re almost to a new decade. Last week, I looked at how this century’s 20s is likely to be far different from the Roaring Twenties of last century. Read More

Did You Make This Trade?

By Adam O'Dell.  |  December 27, 2019

A little over four months ago, I wrote here in The Rich Investor a piece titled: “Do Stocks Have You Confused?” Stocks had me confused, at the time. Still do, in fact. Read More

Seasonality Is Strong, Especially for Biotech

By Adam O'Dell.  |  December 10, 2019

Did you know that November begins the seasonally-favored half of the year for stock returns? I’m sure you’ve heard the Wall Street-ism, “Sell in May and go away. Read More